News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
SSY GROUP Obtains Approvals for Production & Registration for 2 Injection Products
SSY GROUP (02005.HK) announced that it had obtained the approvals for drug production and registration for Multiple Electrolytes, Sodium Acetate and Glucose Injection and Metoclopr...
Reset
Send
The window will close in 5 seconds
SSY GROUP Obtains Approvals for Production & Registration for 2 Injection Products
Close
Recommend
4
Positive
4
Negative
0
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

SSY GROUP (02005.HK)  0.000 (0.000%)    Short selling $4.20M; Ratio 44.896%   announced that it had obtained the approvals for drug production and registration for Multiple Electrolytes, Sodium Acetate and Glucose Injection and Metoclopramide Hydrochloride Injection from the National Medical Products Administration of China, both being under type 3 chemical drug and regarded as passing the consistency evaluation.

Multiple Electrolytes, Sodium Acetate and Glucose Injection is mainly used for replenishment and maintenance of water and electrolytes and for supplying energy when oral administration is impossible or insufficient.

Metoclopramide Hydrochloride Injection is an antiemetic drug which is mainly used for (i) vomiting caused by chemotherapy, radiotherapy, surgery, traumatic brain injury, post-traumatic brain injury, sea and air operations, and drugs; (ii) symptomatic treatment of nausea and vomiting symptoms in various diseases such as acute gastroenteritis, biliary tract and pancreatic diseases, and uremia; and (iii) pre-diagnostic duodenal intubation and barium X-ray examination of the gastrointestinal tract.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-22 16:25.)

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.